Physician profile
Nicole Eichman
NPI 1336801141
$6,673.23
in general payments reported to CMS, 2019-2025
21 companies · $3,112 in 2025
The $3,112 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.18 · 2022: $201 · 2023: $1,905 · 2024: $1,442 · 2025: $3,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,310 · Travel and Lodging: $2,074 · Education: $75.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,309.54 |
| Travel and Lodging | $2,074.28 |
| Education | $75.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,099.99 | 2023-2025 | |
| Novo Nordisk INC | $624.28 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $617.47 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $452.71 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $407.51 | 2022-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $256.60 | 2023-2024 | Camzyos |
| Merck Sharp & Dohme LLC | $217.73 | 2023-2024 | Verquvo |
| Cleerly, INC. | $180.90 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Amgen INC. | $176.18 | 2023-2025 | Repatha, Repatha |
| Lantheus Medical Imaging, INC. | $138.49 | 2023-2025 | Definity |
| Bridgebio Pharma, INC. | $136.93 | 2025 | Attruby |
| Abiomed | $74.88 | 2024-2025 | Impella |
| Esperion Therapeutics, INC. | $57.24 | 2023-2025 | Nexletol |
| Philips North America LLC | $51.90 | 2024 | (Ck4) Mcot, (Ck7) Extended Holter |
| W. L. Gore & Associates, INC. | $38.09 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $29.82 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $28.53 | 2023-2025 | |
| Shockwave Medical, INC | $25.00 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.32 | 2025 | Lifevest |
| G Medical Diagnostic Services, INC. | $20.66 | 2022 | |
| Pfizer INC. | $17.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Eichman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.